Abstract
Somatostatin 28 (S-28) is a peptide produced in the intestinal tract which rises in the circulation during nutrient absorption. We tested the hypothesis that S-28 regulates B-cell function by (a) studying the effects on insulin secretion of "physiologic" infusions of S-28 and (b) measuring insulin responses during elevated nutrient-stimulated endogenous S-28 levels. (a) Synthetic S-28 was infused on separate days into six healthy men at rates of 25 and 50 ng/kg per h which mimicked postprandial levels. Subjects were given a bolus of glucose (0.1 g/kg) after 120 min. Insulin responses during S-28 infusions were compared to a control study using a saline infusion in the same individuals. Glucose-stimulated insulin secretion was inhibited during the infusion of 50 ng/kg per h S-28 when compared to control (P less than 0.05). (b) Insulin secretion during elevations of endogenous S-28 was studied in healthy men who received a bolus of 2.5 g arginine (n = 14) or 25 U of secretin (n = 8) 120 min after swallowing 50 g fat, or, on a separate day, an equivalent volume of water. S-28 levels rose significantly after fat ingestion but did not change after water. Arginine and secretin-stimulated insulin secretion was inhibited following ingestion of fat compared with intake of water (P less than 0.05). Arginine-enhanced glucagon secretion was not changed by fat ingestion. We conclude that elevations in plasma S-28 levels, occurring during the postprandial state, attenuate B-cell secretion and this peptide may be a physiologic modulator of nutrient-stimulated insulin release.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahrén B., Taborsky G. J., Jr, Porte D., Jr Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia. 1986 Dec;29(12):827–836. doi: 10.1007/BF00870137. [DOI] [PubMed] [Google Scholar]
- Amherdt M., Patel Y. C., Orci L. Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest. 1987 Nov;80(5):1455–1458. doi: 10.1172/JCI113225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baldissera F. G., Holst J. J., Jensen S. L., Krarup T. Distribution and molecular forms of peptides containing somatostatin immunodeterminants in extracts from the entire gastrointestinal tract of man and pig. Biochim Biophys Acta. 1985 Jan 28;838(1):132–143. doi: 10.1016/0304-4165(85)90259-4. [DOI] [PubMed] [Google Scholar]
- Bonner-Weir S., Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 1982 Oct;31(10):883–889. doi: 10.2337/diab.31.10.883. [DOI] [PubMed] [Google Scholar]
- Chen M., Porte D., Jr The effect of rate and dose of glucose infusion on the acute insulin response in man. J Clin Endocrinol Metab. 1976 Jun;42(6):1168–1175. doi: 10.1210/jcem-42-6-1168. [DOI] [PubMed] [Google Scholar]
- Chiba T., Park J., Yamada T. Biosynthesis of somatostatin in canine fundic D cells. J Clin Invest. 1988 Feb;81(2):282–287. doi: 10.1172/JCI113319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Creutzfeldt W., Ebert R. New developments in the incretin concept. Diabetologia. 1985 Aug;28(8):565–573. doi: 10.1007/BF00281990. [DOI] [PubMed] [Google Scholar]
- Crockett S. E., Cataland S., Falko J. M., Mazzaferri E. L. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun;42(6):1098–1103. doi: 10.1210/jcem-42-6-1098. [DOI] [PubMed] [Google Scholar]
- Curry D. L., Bennett L. L. Does somatostatin inhibition of insulin secretion involve two mechanisms of action? Proc Natl Acad Sci U S A. 1976 Jan;73(1):248–251. doi: 10.1073/pnas.73.1.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ensinck J. W., Shepard C., Dudl R. J., Williams R. H. Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma. J Clin Endocrinol Metab. 1972 Sep;35(3):463–467. doi: 10.1210/jcem-35-3-463. [DOI] [PubMed] [Google Scholar]
- Gyr K., Beglinger C., Köhler E., Trautzl U., Keller U., Bloom S. R. Circulating somatostatin. Physiological regulator of pancreatic function? J Clin Invest. 1987 Jun;79(6):1595–1600. doi: 10.1172/JCI112994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klaff L. J., Dunning B. E., Taborsky G. J., Jr Somatostatin-28 does not regulate islet function in the dog. Endocrinology. 1988 Dec;123(6):2668–2674. doi: 10.1210/endo-123-6-2668. [DOI] [PubMed] [Google Scholar]
- Klaff L. J., Taborsky G. J., Jr Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia. Diabetes. 1987 May;36(5):592–596. doi: 10.2337/diab.36.5.592. [DOI] [PubMed] [Google Scholar]
- Klaff L. J., Taborsky G. J., Jr Role of pancreatic somatostatin in determining glucagon response to arginine and morphine. Am J Physiol. 1987 Jun;252(6 Pt 1):E751–E755. doi: 10.1152/ajpendo.1987.252.6.E751. [DOI] [PubMed] [Google Scholar]
- Konturek S. J., Kwiecień N., Obtułowicz W., Bielański W., Oleksy J., Schally A. V. Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man. Scand J Gastroenterol. 1985 Jan;20(1):31–38. doi: 10.3109/00365528509089629. [DOI] [PubMed] [Google Scholar]
- Kreymann B., Williams G., Ghatei M. A., Bloom S. R. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987 Dec 5;2(8571):1300–1304. doi: 10.1016/s0140-6736(87)91194-9. [DOI] [PubMed] [Google Scholar]
- Larsson L. I., Goltermann N., de Magistris L., Rehfeld J. F., Schwartz T. W. Somatostatin cell processes as pathways for paracrine secretion. Science. 1979 Sep 28;205(4413):1393–1395. doi: 10.1126/science.382360. [DOI] [PubMed] [Google Scholar]
- Lucey M. R., Fairclough P. D., Wass J. A., Kwasowski P., Medbak S., Webb J., Rees L. H. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man. Clin Endocrinol (Oxf) 1984 Sep;21(3):209–217. doi: 10.1111/j.1365-2265.1984.tb03461.x. [DOI] [PubMed] [Google Scholar]
- Mandarino L., Stenner D., Blanchard W., Nissen S., Gerich J., Ling N., Brazeau P., Bohlen P., Esch F., Guillemin R. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 1981 May 7;291(5810):76–77. doi: 10.1038/291076a0. [DOI] [PubMed] [Google Scholar]
- Marco J., Correas I., Zulueta M. A., Vincent E., Coy D. H., Comaru-Schally A. M., Schally A. V., Rodríguez-Arnao M. D., Gómez-Pan A. Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man. Horm Metab Res. 1983 Aug;15(8):363–366. doi: 10.1055/s-2007-1018725. [DOI] [PubMed] [Google Scholar]
- Meyers C. A., Murphy W. A., Redding T. W., Coy D. H., Schally A. V. Synthesis and biological actions of prosomatostatin. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6171–6174. doi: 10.1073/pnas.77.10.6171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mojsov S., Weir G. C., Habener J. F. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest. 1987 Feb;79(2):616–619. doi: 10.1172/JCI112855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel Y. C., Wheatley T., Ning C. Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat. Endocrinology. 1981 Dec;109(6):1943–1949. doi: 10.1210/endo-109-6-1943. [DOI] [PubMed] [Google Scholar]
- Penman E., Wass J. A., Medbak S., Morgan L., Lewis J. M., Besser G. M., Rees L. H. Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects. Gastroenterology. 1981 Oct;81(4):692–699. [PubMed] [Google Scholar]
- Polonsky K. S., Given B. D., Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988 Feb;81(2):442–448. doi: 10.1172/JCI113339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polonsky K. S., Shoelson S. E., Docherty H. M. Plasma somatostatin 28 increases in response to feeding in man. J Clin Invest. 1983 May;71(5):1514–1518. doi: 10.1172/JCI110907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ravazzola M., Benoit R., Ling N., Guillemin R., Orci L. Immunocytochemical localization of prosomatostatin fragments in maturing and mature secretory granules of pancreatic and gastrointestinal D cells. Proc Natl Acad Sci U S A. 1983 Jan;80(1):215–218. doi: 10.1073/pnas.80.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reichlin S. Somatostatin (second of two parts). N Engl J Med. 1983 Dec 22;309(25):1556–1563. doi: 10.1056/NEJM198312223092506. [DOI] [PubMed] [Google Scholar]
- Samols E., Stagner J. I., Ewart R. B., Marks V. The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas. J Clin Invest. 1988 Jul;82(1):350–353. doi: 10.1172/JCI113593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shoelson S. E., Polonsky K. S., Nakabayashi T., Jaspan J. B., Tager H. S. Circulating forms of somatostatinlike immunoreactivity in human plasma. Am J Physiol. 1986 Apr;250(4 Pt 1):E428–E434. doi: 10.1152/ajpendo.1986.250.4.E428. [DOI] [PubMed] [Google Scholar]
- Smith C. P., Tarn A. C., Thomas J. M., Overkamp D., Corakci A., Savage M. O., Gale E. A. Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia. 1988 Feb;31(2):123–125. doi: 10.1007/BF00395560. [DOI] [PubMed] [Google Scholar]
- Souquet J. C., Rambliere R., Riou J. P., Beylot M., Cohen R., Mornex R., Chayvialle J. A. Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14. J Clin Endocrinol Metab. 1983 May;56(5):1076–1079. doi: 10.1210/jcem-56-5-1076. [DOI] [PubMed] [Google Scholar]
- Zaharko D. S., Beck L. V. Studies of a simplified plasma insulin immunoassaay using cellulose powder. Diabetes. 1968 Jul;17(7):444–459. doi: 10.2337/diab.17.7.444. [DOI] [PubMed] [Google Scholar]
- Zyznar E. S., Pietri A. O., Harris V., Unger R. H. Evidence for the hormonal status of somatostatin in man. Diabetes. 1981 Oct;30(10):883–886. doi: 10.2337/diab.30.10.883. [DOI] [PubMed] [Google Scholar]